{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T21:30:57Z","timestamp":1767994257513,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T00:00:00Z","timestamp":1434585600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s10067-015-2993-z","type":"journal-article","created":{"date-parts":[[2015,6,16]],"date-time":"2015-06-16T22:56:54Z","timestamp":1434495414000},"page":"807-812","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["MDS and GCA: a prognostic dilemma"],"prefix":"10.1007","volume":"35","author":[{"given":"Neha G.","family":"Narula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andy","family":"Abril","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,18]]},"reference":[{"issue":"4","key":"2993_CR1","first-page":"339","volume":"12","author":"NI Berlin","year":"1975","unstructured":"Berlin NI (1975) Diagnosis and classification of the polycythemias. Semin Hematol 12(4):339\u2013351","journal-title":"Semin Hematol"},{"key":"2993_CR2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/10428199309148503","volume":"9","author":"JA Savage","year":"1993","unstructured":"Savage JA, Chang L, Smith CL, Duggan JC (1993) Myelodysplasia, vasculitis and anti neutrophil cytoplasm antibodies. Leuk Lymphoma 9:49\u201355","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"2993_CR3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00062752-199809000-00004","volume":"5","author":"R Landolfi","year":"1998","unstructured":"Landolfi R (1998) Bleeding and thrombosis in myeloproliferative disorders. Curr Opin Hematol 5(5):327\u2013331","journal-title":"Curr Opin Hematol"},{"issue":"4","key":"2993_CR4","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1182\/blood.V99.4.1144","volume":"99","author":"MB Streiff","year":"2002","unstructured":"Streiff MB, Smith B, Spivak JL (2002) The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members\u2019 practice patterns. Blood 99(4):1144\u20131149","journal-title":"Blood"},{"issue":"4","key":"2993_CR5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s100670200081","volume":"21","author":"G Espinosa","year":"2002","unstructured":"Espinosa G, Font J, Mu\u00f1oz-Rodr\u00edguez FJ, Cervera R, Ingelmo M (2002) Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: a coincidental coexistence or a causal relationship? Clin Rheumatol 21(4):309\u2013313","journal-title":"Clin Rheumatol"},{"issue":"4","key":"2993_CR6","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1182\/blood.V6.4.372.372","volume":"6","author":"W Dameshek","year":"1951","unstructured":"Dameshek W (1951) Some speculations on the myeloproliferative syndromes. Blood 6(4):372\u2013375","journal-title":"Blood"},{"issue":"5","key":"2993_CR7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1200\/JCO.2010.29.8711","volume":"29","author":"A Tefferi","year":"2011","unstructured":"Tefferi A, Vainchenker W (2011) Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies. J Clin Oncol 29(5):573\u2013582","journal-title":"J Clin Oncol"},{"issue":"14","key":"2993_CR8","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1182\/blood-2011-11-394775","volume":"119","author":"HC Hasselbalch","year":"2011","unstructured":"Hasselbalch HC (2011) Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer? Blood 119(14):3219\u20133225","journal-title":"Blood"},{"issue":"4","key":"2993_CR9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ajh.2830340411","volume":"34","author":"H Hasselbalch","year":"1990","unstructured":"Hasselbalch H (1990) Idiopathic myelofibrosis: a clinical study of 80 patients. Am J Hematol 34(4):291\u2013300","journal-title":"Am J Hematol"},{"issue":"7","key":"2993_CR10","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3324\/haematol.2009.020412","volume":"95","author":"SY Kristinsson","year":"2010","unstructured":"Kristinsson SY, Landgren O, Samuelsson J, Bj\u00f6rkholm M, Goldin LR (2010) Autoimmunity and the risk of myeloproliferative neoplasms. Haematologica 95(7):1216\u20131220","journal-title":"Haematologica"},{"issue":"3","key":"2993_CR11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2141.1983.tb02048.x","volume":"53","author":"E Rondeau","year":"1983","unstructured":"Rondeau E, Solal-Celigny P, Dhermy D, Vroclans M, Brousse N, Bernard JF, Boivin P (1983) Immune disorders in agnogenic myeloid metaplasia: relations to myelofibrosis. Br J Haematol 53(3):467\u2013475","journal-title":"Br J Haematol"},{"issue":"2","key":"2993_CR12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1600-0609.1985.tb02252.x","volume":"34","author":"H Hasselbalch","year":"1985","unstructured":"Hasselbalch H, Nielsen H, Berild D, Kappelgaard E (1985) Circulating immune complexes in myelofibrosis. Scand J Haematol 34(2):177\u2013180","journal-title":"Scand J Haematol"},{"issue":"3","key":"2993_CR13","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/10428190310001597982","volume":"45","author":"R Rizzi","year":"2004","unstructured":"Rizzi R, Pastore D, Liso A, Liuzzi GM, Dalena AM, Specchia G, Ricco R, Liso V (2004) Autoimmune myelofibrosis: report of three cases and review of the literature. Leuk Lymphoma 45(3):561\u2013566","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"2993_CR14","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.leukres.2010.05.010","volume":"34","author":"G Barosi","year":"2010","unstructured":"Barosi G, Magrini U, Gale RP (2010) Does auto-immunity contribute to anemia in myeloproliferative neoplasms (MPN)-associated myelofibrosis? Leuk Res 34(9):1119\u20131120","journal-title":"Leuk Res"},{"key":"2993_CR15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1056\/NEJMra022694","volume":"349","author":"CM Weyand","year":"2003","unstructured":"Weyand CM, Goronzy JJ (2003) Medium- and large-vessel vasculitis. N Engl J Med 349:160\u2013169","journal-title":"N Engl J Med"},{"key":"2993_CR16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/WNO.0b013e318268aa9b","volume":"32","author":"CM Weyand","year":"2012","unstructured":"Weyand CM, Liao YJ, Goronzy JJ (2012) The immunopathology of giant cell arteritis: diagnostic and therapeutic implications. J Neuroophthalmol 32:259\u2013265","journal-title":"J Neuroophthalmol"},{"key":"2993_CR17","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0161-6420(93)31608-8","volume":"100","author":"PD Aiello","year":"1993","unstructured":"Aiello PD, Trautmann JC, McPhee TJ, Kunselman AR, Hunder GG (1993) Visual prognosis in giant cell arteritis. Ophthalmology 100:550\u2013555","journal-title":"Ophthalmology"},{"key":"2993_CR18","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/01.pas.0000213293.04026.ec","volume":"30","author":"DV Miller","year":"2006","unstructured":"Miller DV, Isotalo PA, Weyand CM, Edwards WD, Aubry MC, Tazelaar HD (2006) Surgical pathology of noninfectious ascending aortitis: a study of 45 cases with emphasis on an isolated variant. Am J Surg Pathol 30:1150\u20131158","journal-title":"Am J Surg Pathol"},{"key":"2993_CR19","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/art.24459","volume":"61","author":"MA Gonzalez-Gay","year":"2009","unstructured":"Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, Miranda-Filloy JA, Gonzalez-Juanatey C, Martin J, Llorca J (2009) Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum 61:1454\u201314561","journal-title":"Arthritis Rheum"},{"key":"2993_CR20","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/art.30155","volume":"63","author":"CS Crowson","year":"2011","unstructured":"Crowson CS, Matteson EL, Myasoedova E, Michet CJ, Ernste FC, Warrington KJ, Davis JM 3rd, Hunder GG, Therneau TM, Gabriel SE (2011) The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum 63:633\u2013639","journal-title":"Arthritis Rheum"},{"key":"2993_CR21","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3109\/03009742.2013.793777","volume":"42","author":"B Z\u00f6ller","year":"2013","unstructured":"Z\u00f6ller B, Li X, Sundquist J, Sundquist K (2013) Occupational and socio-economic risk factors for giant cell arteritis: a nationwide study based on hospitalizations in Sweden. Scand J Rheumatol 42:487\u2013497","journal-title":"Scand J Rheumatol"},{"key":"2993_CR22","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2013.161","volume":"9","author":"CM Weyand","year":"2013","unstructured":"Weyand CM, Goronzy JJ (2013) Immune mechanisms in medium and large-vessel vasculitis. Nat Rev Rheumatol 9:731\u2013740","journal-title":"Nat Rev Rheumatol"},{"key":"2993_CR23","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1161\/CIRCULATIONAHA.108.789172","volume":"118","author":"O Pryshchep","year":"2008","unstructured":"Pryshchep O, Ma-Krupa W, Younge BR, Goronzy JJ, Weyand CM (2008) Vessel-specific Toll-like receptor profiles in human medium and large arteries. Circulation 118:1276\u20131284","journal-title":"Circulation"},{"key":"2993_CR24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/BOR.0b013e32833ee946","volume":"23","author":"CM Weyand","year":"2011","unstructured":"Weyand CM, Younge BR, Goronzy JJ (2011) IFN-\u03b3 and IL-17: the two faces of T-cell pathology in giant cell arteritis. Curr Opin Rheumatol 23:43\u201349","journal-title":"Curr Opin Rheumatol"},{"key":"2993_CR25","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1161\/CIRCULATIONAHA.109.872903","volume":"121","author":"J Deng","year":"2010","unstructured":"Deng J, Younge BR, Olshen RA, Goronzy JJ, Weyand CM (2010) Th17 and Th1 Tcell responses in giant cell arteritis. Circulation 121:906\u2013915","journal-title":"Circulation"},{"issue":"17","key":"2993_CR26","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMc1409960","volume":"371","author":"CM Weyand","year":"2014","unstructured":"Weyand CM, Goronzy JJ (2014) Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med 371(17):1653","journal-title":"N Engl J Med"},{"key":"2993_CR27","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/ard.2008.088351","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T, Hellmich B, Jayne D, Kallenberg CG, Merkel PA, Raspe H, Salvarani C, Scott DG, Stegeman C, Watts R, Westman K, Witter J, Yazici H, Luqmani R (2009) European Vasculitis Study Group. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 68:318\u2013323","journal-title":"Ann Rheum Dis"},{"key":"2993_CR28","doi-asserted-by":"crossref","first-page":"631","DOI":"10.7326\/0003-4819-146-9-200705010-00005","volume":"146","author":"C Salvarani","year":"2007","unstructured":"Salvarani C, Macchioni P, Manzini C, Paolazzi G, Trotta A, Manganelli P, Cimmino M, Gerli R, Catanoso MG, Boiardi L, Cantini F, Klersy C, Hunder GG (2007) Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial. Ann Intern Med 146:631\u2013639","journal-title":"Ann Intern Med"},{"key":"2993_CR29","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-146-9-200705010-00004","volume":"146","author":"GS Hoffman","year":"2007","unstructured":"Hoffman GS, Cid MC, Rendt-Zagar KE, Merkel PA, Weyand CM, Stone JH, Salvarani C, Xu W, Visvanathan S, Rahman MU, Infliximab-GCA Study Group (2007) Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. Ann Intern Med 146:621\u2013630","journal-title":"Ann Intern Med"},{"key":"2993_CR30","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/10428199709055585","volume":"24","author":"H Enright","year":"1997","unstructured":"Enright H, Miller W (1997) Autoimmune phenomena in patients with myelodysplastic syndromes. Leuk Lymphoma 24:483\u2013489","journal-title":"Leuk Lymphoma"},{"key":"2993_CR31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2169\/internalmedicine.53.0949","volume":"53","author":"T Katsuyama","year":"2014","unstructured":"Katsuyama T, Uchida HA, Toma K, Maeda Y, Hirota D, Umebayashi R, Sada KE, Makino H (2014) Large vessel vasculitis with myelodysplastic syndrome. Intern Med 53:63\u201366","journal-title":"Intern Med"},{"key":"2993_CR32","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3324\/haematol.2009.006080","volume":"94","author":"AJ Barrett","year":"2009","unstructured":"Barrett AJ, Sloand E (2009) Autoimmune mechanisms in the pathophysiology of myelodysplastic syndromes and their clinical relevance. Haematologica 94:449\u2013451","journal-title":"Haematologica"},{"key":"2993_CR33","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.autrev.2011.11.025","volume":"11","author":"C Comarmond","year":"2012","unstructured":"Comarmond C, Plaisier E, Dahan K, Mirault T, Emmerich J, Amoura Z, Cacoub P, Saadoun D (2012) Anti TNF-in refractory Takayasu\u2019s arteritis: cases series and review of the literature. Autoimmun Rev 11:678\u2013684","journal-title":"Autoimmun Rev"},{"key":"2993_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CGM, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DGI, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitis. Arthritis Rheum 65:1\u201311","journal-title":"Arthritis Rheum"},{"key":"2993_CR35","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.autrev.2013.01.005","volume":"10","author":"C Belizna","year":"2013","unstructured":"Belizna C, Subra JF, Henrion D, Ghali A, Renier G, Royer M, Corre YL, Martin L, Voswinkel J, Ifrah N (2013) Prognosis of vasculitis associated myelodysplasia. Autoimmun Rev 10:943\u2013946","journal-title":"Autoimmun Rev"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-2993-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-015-2993-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-2993-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T16:08:56Z","timestamp":1599149336000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-015-2993-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,18]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["2993"],"URL":"https:\/\/doi.org\/10.1007\/s10067-015-2993-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,18]]}}}